Vion Pharmaceuticals, Inc

have been watching this one for a couple of weeks now and like it so am starting a thread... looks like it found bottom and may be setting up for a nice move north....

Shares Outstanding = 75.5M
Institutional Ownership =22.07%
Market Cap = 44.5M

insider buying earlier this year.

Vion Pharmaceuticals, Inc.. The Group's principal activity is the research, development and marketing of therapeutics and technologies for the treatment of cancer. It is a development stage biopharmaceutical company. Its portfolio of potential products consists of two distinct small molecule anticancer agents in clinical development, and additional small molecules and a drug delivery system in preclinical development. The Company has CLORETAZINETM (VNP40101M) and Triapine(R) products are in the clinical development and KS119, Heterocyclic hydrazones and TAPET(R) products are in the preclinical development stage.

last pr= losses but
VION PHARMACEUTICALS INC
Vion Reports 2007 Third Quarter and Nine-Month Results
11/7/2007 http://www.stockhouse.com/news/news....1375&tick=VION